Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Advances in diagnosis, classification, and management of pain in Parkinson's disease
Comorbidities as risk factors for migraine onset: a systematic review and three-level meta-analysis
Cortisol and 10-year cognitive decline in older people from the general population
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
The effects of disease-modifying therapies on optic nerve degeneration in multiple sclerosis
Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over (new NICE guideline TA1050)
Fractures in hereditary neuromuscular disorders: frequency, risk factors, and implications
Free water as a marker of early small vessel disease in healthy aging
Multiple sclerosis and COVID-19: interactions and unresolved issues
Neurological Long COVID in the outpatient clinic: is it so long?
Neuroprotective mechanisms of exercise and the importance of fitness for healthy brain ageing
Reactive pleocytosis after repeated lumbar puncture—implications for clinical practice
Rituximab for people with multiple sclerosis (new Cochrane intervention review)
Sulfonylurea drugs for people with severe hemispheric ischemic stroke (new Cochrane intervention review)
BMC Neurology (Mar); BMJ, The (Mar); Cochrane Library (Mar-Apr); European Journal of Neurology (Mar-Apr); Lancet, The (Mar); Lancet Neurology, The (Mar-Apr); NICE website (Mar)
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention
Cognitive deficits and cortical volume loss in COVID-19-related hyposmia
Cognitive domains affected post-COVID-19: a systematic review and meta-analysis
Comorbidities and neurosurgical interventions in a cohort with connective tissue disorders
Diagnosis and management of status epilepticus: improving the status quo
Epilepsies in children, young people and adults (updated NICE guideline NG217)
The European Academy of Neurology NeuroCOVID-19 Task Force: a lesson for the future
Functional connectivity and metabolic brain alterations in sleepwalkers
The influence of menopause on multiple sclerosis
Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: a systematic review
Neurocognitive performance in functional neurological disorder
Perspectives on the diagnosis and management of functional cognitive disorder
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
Spontaneous intracranial hypotension — neurological symptoms, diagnosis, and outcome
Unique considerations in the assessment and management of traumatic brain injury in older adults
Annals of Clinical and Translational Neurology (Oct-Nov); European Journal of Neurology (Jan-Feb); Frontiers in Neurology (Jan); Lancet Neurology, The (Jan-Feb)
Antiseizure medications and cardiovascular events in older people with epilepsy
Antiseizure medication use and outcomes after suspected or confirmed acute symptomatic seizures
Azathioprine for people with multiple sclerosis (new Cochrane intervention review)
Beyond seizure freedom: reduction in anti-seizure medication after epilepsy surgery
Clinical trials for Lennox–Gastaut syndrome: challenges and priorities
Comorbidity and disease activity in multiple sclerosis
Dysphagia assessment in patients with multiple sclerosis – an additional piece to disability burden
Hearing loss, incident Parkinson disease, and treatment with hearing aids
Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment
Neurotoxicity of per- and polyfluoroalkyl substances: evidence and future directions
Perceived chronic traumatic encephalopathy and suicidality in former professional football players
Rituximab in secondary progressive multiple sclerosis: a meta-analysis
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic
Annals of Clinical and Translational Neurology (Oct-Nov); Cochrane Library (Nov-Dec); Epilepsy Research (Dec); JAMA Neurology (Nov-Dec); Journal of Hazardous Materials (Dec); Lancet Neurology (Dec)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.